{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T17:47:00Z","timestamp":1795110420737,"version":"4.10.3"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"This work was supported by Muscular Dystrophy Association Cyprus\/Telethon Cyprus and Pfizer\u2019s GLOBAL Aspire Grants.","award":["This work was supported by Muscular Dystrophy Association Cyprus\/Telethon Cyprus and Pfizer\u2019s GLOBAL Aspire Grants."],"award-info":[{"award-number":["This work was supported by Muscular Dystrophy Association Cyprus\/Telethon Cyprus and Pfizer\u2019s GLOBAL Aspire Grants."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s10072-019-04176-9","type":"journal-article","created":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T18:08:30Z","timestamp":1577988510000},"page":"1163-1170","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["The frequency of central nervous system complications in the Cypriot cohort of ATTRV30M neuropathy transplanted patients"],"prefix":"10.1007","volume":"41","author":[{"given":"Efthimios","family":"Dardiotis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savanna","family":"Andreou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athina-Maria","family":"Aloizou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Panayiotou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasileios","family":"Siokas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela Nedea","family":"Ioannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmelia","family":"Vounou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyproula","family":"Christodoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A.","family":"Tanteles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demos","family":"Michaelides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros","family":"Kyriakides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,2]]},"reference":[{"issue":"1","key":"4176_CR1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1080\/13506120802676948","volume":"16","author":"E Dardiotis","year":"2009","unstructured":"Dardiotis E, Koutsou P, Papanicolaou EZ, Vonta I, Kladi A, Vassilopoulos D, Hadjigeorgiou G, Christodoulou K, Kyriakides T (2009) Epidemiological, clinical and genetic study of familial amyloidotic polyneuropathy in Cyprus. Amyloid 16(1):32\u201337. https:\/\/doi.org\/10.1080\/13506120802676948","journal-title":"Amyloid"},{"issue":"9","key":"4176_CR2","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1136\/jnnp-2014-308724","volume":"86","author":"Y Sekijima","year":"2015","unstructured":"Sekijima Y (2015) Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments. J Neurol Neurosurg Psychiatry 86(9):1036\u20131043. https:\/\/doi.org\/10.1136\/jnnp-2014-308724","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"4176_CR3","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s10072-019-03778-7","volume":"40","author":"G Vita","year":"2019","unstructured":"Vita G, Vita GL, Stancanelli C, Gentile L, Russo M, Mazzeo A (2019) Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 1: peripheral neuropathies. Neurol Sci 40(4):661\u2013669. https:\/\/doi.org\/10.1007\/s10072-019-03778-7","journal-title":"Neurol Sci"},{"issue":"2","key":"4176_CR4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s10072-016-2760-1","volume":"38","author":"EF de Paula","year":"2017","unstructured":"de Paula EF, de Mello BL, de Carvalho DL, Della-Guardia B, de Almeida MD, Marins LV, Correa L (2017) Minor salivary gland biopsy for the diagnosis of familial amyloid polyneuropathy. Neurol Sci 38(2):311\u2013318. https:\/\/doi.org\/10.1007\/s10072-016-2760-1","journal-title":"Neurol Sci"},{"issue":"7","key":"4176_CR5","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1111\/j.1742-4658.2007.05712.x","volume":"274","author":"X Hou","year":"2007","unstructured":"Hou X, Aguilar MI, Small DH (2007) Transthyretin and familial amyloidotic polyneuropathy. Recent progress in understanding the molecular mechanism of neurodegeneration. FEBS J 274(7):1637\u20131650. https:\/\/doi.org\/10.1111\/j.1742-4658.2007.05712.x","journal-title":"FEBS J"},{"issue":"1","key":"4176_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/13506120410001673884","volume":"11","author":"L Lobato","year":"2004","unstructured":"Lobato L, Beirao I, Silva M, Fonseca I, Queiros J, Rocha G, Sarmento AM, Sousa A, Sequeiros J (2004) End-stage renal disease and dialysis in hereditary amyloidosis TTR V30M: presentation, survival and prognostic factors. Amyloid 11(1):27\u201337","journal-title":"Amyloid"},{"key":"4176_CR7","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0065-3233(08)60321-6","volume":"50","author":"JW Kelly","year":"1997","unstructured":"Kelly JW, Colon W, Lai Z, Lashuel HA, McCulloch J, McCutchen SL, Miroy GJ, Peterson SA (1997) Transthyretin quaternary and tertiary structural changes facilitate misassembly into amyloid. Adv Protein Chem 50:161\u2013181","journal-title":"Adv Protein Chem"},{"issue":"5","key":"4176_CR8","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/00019052-200010000-00011","volume":"13","author":"V Plante-Bordeneuve","year":"2000","unstructured":"Plante-Bordeneuve V, Said G (2000) Transthyretin related familial amyloid polyneuropathy. Curr Opin Neurol 13(5):569\u2013573","journal-title":"Curr Opin Neurol"},{"issue":"3","key":"4176_CR9","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/brain\/75.3.408","volume":"75","author":"C Andrade","year":"1952","unstructured":"Andrade C (1952) A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 75(3):408\u2013427","journal-title":"Brain"},{"issue":"1","key":"4176_CR10","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/mus.20644","volume":"35","author":"I Conceicao","year":"2007","unstructured":"Conceicao I, De Carvalho M (2007) Clinical variability in type I familial amyloid polyneuropathy (Val30Met): comparison between late- and early-onset cases in Portugal. Muscle Nerve 35(1):116\u2013118. https:\/\/doi.org\/10.1002\/mus.20644","journal-title":"Muscle Nerve"},{"issue":"6","key":"4176_CR11","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ajmg.1320600606","volume":"60","author":"A Sousa","year":"1995","unstructured":"Sousa A, Coelho T, Barros J, Sequeiros J (1995) Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in Povoa do Varzim and Vila do Conde (north of Portugal). Am J Med Genet 60(6):512\u2013521. https:\/\/doi.org\/10.1002\/ajmg.1320600606","journal-title":"Am J Med Genet"},{"issue":"2","key":"4176_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3109\/13506129.2014.994597","volume":"22","author":"A Iorio","year":"2015","unstructured":"Iorio A, De Angelis F, Di Girolamo M, Luigetti M, Pradotto L, Mauro A, Manfellotto D, Fuciarelli M, Polimanti R (2015) Most recent common ancestor of TTR Val30Met mutation in Italian population and its potential role in genotype-phenotype correlation. Amyloid 22(2):73\u201378. https:\/\/doi.org\/10.3109\/13506129.2014.994597","journal-title":"Amyloid"},{"issue":"1","key":"4176_CR13","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1080\/13506120500032741","volume":"12","author":"M Munar-Ques","year":"2005","unstructured":"Munar-Ques M, Saraiva MJ, Viader-Farre C, Zabay-Becerril JM, Mulet-Ferrer J (2005) Genetic epidemiology of familial amyloid polyneuropathy in the Balearic Islands (Spain). Amyloid 12(1):54\u201361. https:\/\/doi.org\/10.1080\/13506120500032741","journal-title":"Amyloid"},{"key":"4176_CR14","first-page":"1","volume":"590","author":"R Andersson","year":"1976","unstructured":"Andersson R (1976) Familial amyloidosis with polyneuropathy. A clinical study based on patients living in northern Sweden. Acta Medica Scand Suppl 590:1\u201364","journal-title":"Acta Medica Scand Suppl"},{"issue":"11","key":"4176_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0049981","volume":"7","author":"N Norgren","year":"2012","unstructured":"Norgren N, Hellman U, Ericzon BG, Olsson M, Suhr OB (2012) Allele specific expression of the transthyretin gene in swedish patients with hereditary transthyretin amyloidosis (ATTR V30M) is similar between the two alleles. PLoS One 7(11):e49981. https:\/\/doi.org\/10.1371\/journal.pone.0049981","journal-title":"PLoS One"},{"issue":"5","key":"4176_CR16","first-page":"334","volume":"24","author":"S Sakoda","year":"1983","unstructured":"Sakoda S, Suzuki T, Higa S, Ueji M, Kishimoto S, Hayashi A, Yasuda N, Takaba Y, Nakajima A (1983) Genetic studies of familial amyloid polyneuropathy in the Arao district of Japan: I. The genealogical survey. Clin Genet 24(5):334\u2013338","journal-title":"Clin Genet"},{"issue":"4","key":"4176_CR17","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/cge.12500","volume":"88","author":"DB Zhen","year":"2015","unstructured":"Zhen DB, Swiecicki PL, Zeldenrust SR, Dispenzieri A, Mauermann ML, Gertz MA (2015) Frequencies and geographic distributions of genetic mutations in transthyretin- and non-transthyretin-related familial amyloidosis. Clin Genet 88(4):396\u2013400. https:\/\/doi.org\/10.1111\/cge.12500","journal-title":"Clin Genet"},{"issue":"8637","key":"4176_CR18","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0140-6736(89)90068-8","volume":"1","author":"IJ Holt","year":"1989","unstructured":"Holt IJ, Harding AE, Middleton L, Chrysostomou G, Said G, King RH, Thomas PK (1989) Molecular genetics of amyloid neuropathy in Europe. Lancet 1(8637):524\u2013526","journal-title":"Lancet"},{"key":"4176_CR19","doi-asserted-by":"publisher","unstructured":"Andreou S, Panayiotou E, Michailidou K, Pirpa P, Hadjisavvas A, El Salloukh A, Barnes D, Antoniou A, Agathangelou P, Papastavrou K, Christodoulou K, Tanteles GA, Kyriakides T (2018) Epidemiology of ATTRV30M neuropathy in Cyprus and the modifier effect of complement C1q on the age of disease onset. Amyloid:1\u20137. https:\/\/doi.org\/10.1080\/13506129.2018.1534731","DOI":"10.1080\/13506129.2018.1534731"},{"issue":"6","key":"4176_CR20","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1136\/jnnp.56.6.694","volume":"56","author":"K Bhatia","year":"1993","unstructured":"Bhatia K, Reilly M, Adams D, Davis MB, Hawkes CH, Thomas PK, Said G, Harding AE (1993) Transthyretin gene mutations in British and French patients with amyloid neuropathy. J Neurol Neurosurg Psychiatry 56(6):694\u2013697","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"4176_CR21","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1007\/BF00866917","volume":"242","author":"MM Reilly","year":"1995","unstructured":"Reilly MM, Adams D, Davis MB, Said G, Harding AE (1995) Haplotype analysis of French, British and other European patients with familial amyloid polyneuropathy (met 30 and tyr 77). J Neurol 242(10):664\u2013668","journal-title":"J Neurol"},{"issue":"3","key":"4176_CR22","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/BF00210422","volume":"96","author":"MR Almeida","year":"1995","unstructured":"Almeida MR, Aoyama-Oishi N, Sakaki Y, Holmgren G, Ulf D, Ferlini A, Salvi F, Munar-Oues M, Benson MD, Skinner M et al (1995) Haplotype analysis of common transthyretin mutations. Hum Genet 96(3):350\u2013354","journal-title":"Hum Genet"},{"issue":"1\u20132","key":"4176_CR23","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jns.2009.05.018","volume":"284","author":"E Dardiotis","year":"2009","unstructured":"Dardiotis E, Koutsou P, Zamba-Papanicolaou E, Vonta I, Hadjivassiliou M, Hadjigeorgiou G, Cariolou M, Christodoulou K, Kyriakides T (2009) Complement C1Q polymorphisms modulate onset in familial amyloidotic polyneuropathy TTR Val30Met. J Neurol Sci 284(1\u20132):158\u2013162. https:\/\/doi.org\/10.1016\/j.jns.2009.05.018","journal-title":"J Neurol Sci"},{"issue":"2","key":"4176_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3109\/13506129.2010.483114","volume":"17","author":"R Hornsten","year":"2010","unstructured":"Hornsten R, Pennlert J, Wiklund U, Lindqvist P, Jensen SM, Suhr OB (2010) Heart complications in familial transthyretin amyloidosis: impact of age and gender. Amyloid 17(2):63\u201368. https:\/\/doi.org\/10.3109\/13506129.2010.483114","journal-title":"Amyloid"},{"issue":"5","key":"4176_CR25","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/00019052-200410000-00012","volume":"17","author":"AJ Stangou","year":"2004","unstructured":"Stangou AJ, Hawkins PN (2004) Liver transplantation in transthyretin-related familial amyloid polyneuropathy. Curr Opin Neurol 17(5):615\u2013620","journal-title":"Curr Opin Neurol"},{"issue":"12","key":"4176_CR26","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/S1474-4422(11)70246-0","volume":"10","author":"V Plante-Bordeneuve","year":"2011","unstructured":"Plante-Bordeneuve V, Said G (2011) Familial amyloid polyneuropathy. Lancet Neurol 10(12):1086\u20131097. https:\/\/doi.org\/10.1016\/S1474-4422(11)70246-0","journal-title":"Lancet Neurol"},{"issue":"5","key":"4176_CR27","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/00019052-199610000-00007","volume":"9","author":"T Coelho","year":"1996","unstructured":"Coelho T (1996) Familial amyloid polyneuropathy: new developments in genetics and treatment. Curr Opin Neurol 9(5):355\u2013359","journal-title":"Curr Opin Neurol"},{"issue":"8853","key":"4176_CR28","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/0140-6736(93)93127-M","volume":"341","author":"G Holmgren","year":"1993","unstructured":"Holmgren G, Ericzon BG, Groth CG, Steen L, Suhr O, Andersen O, Wallin BG, Seymour A, Richardson S, Hawkins PN et al (1993) Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 341(8853):1113\u20131116","journal-title":"Lancet"},{"issue":"Pt 7","key":"4176_CR29","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1093\/brain\/123.7.1495","volume":"123","author":"D Adams","year":"2000","unstructured":"Adams D, Samuel D, Goulon-Goeau C, Nakazato M, Costa PM, Feray C, Plante V, Ducot B, Ichai P, Lacroix C, Metral S, Bismuth H, Said G (2000) The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation. Brain 123(Pt 7):1495\u20131504","journal-title":"Brain"},{"issue":"3","key":"4176_CR30","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3109\/13506120209114824","volume":"9","author":"WD Lewis","year":"2002","unstructured":"Lewis WD (2002) Liver transplantation: an effective treatment for familial ATTR amyloidosis. Amyloid 9(3):201\u2013202","journal-title":"Amyloid"},{"issue":"Suppl 1","key":"4176_CR31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3109\/13506129.2011.574354072","volume":"18","author":"HE Wilczek","year":"2011","unstructured":"Wilczek HE, Larsson M, Ericzon BG, Fapwtr (2011) Long-term data from the Familial Amyloidotic Polyneuropathy World Transplant Registry (FAPWTR). Amyloid 18(Suppl 1):193\u2013195. https:\/\/doi.org\/10.3109\/13506129.2011.574354072","journal-title":"Amyloid"},{"issue":"9","key":"4176_CR32","doi-asserted-by":"publisher","first-page":"e212","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.04.033","volume":"27","author":"F Salvi","year":"2018","unstructured":"Salvi F, Volpe R, Pastorelli F, Bianchi A, Vella A, Rapezzi C, Mascalchi M (2018) Failure of tafamidis to halt progression of Ala36Pro TTR Oculomeningovascular amyloidosis. J Stroke Cerebrovasc Dis 27(9):e212\u2013e214. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2018.04.033","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"3","key":"4176_CR33","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/01.TP.0000111516.60013.E6","volume":"77","author":"Y Ando","year":"2004","unstructured":"Ando Y, Terazaki H, Nakamura M, Ando E, Haraoka K, Yamashita T, Ueda M, Okabe H, Sasaki Y, Tanihara H, Uchino M, Inomata Y (2004) A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation. Transplantation 77(3):345\u2013349. https:\/\/doi.org\/10.1097\/01.TP.0000111516.60013.E6","journal-title":"Transplantation"},{"issue":"2","key":"4176_CR34","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/jnnp-2014-308107","volume":"86","author":"LF Maia","year":"2015","unstructured":"Maia LF, Magalhaes R, Freitas J, Taipa R, Pires MM, Osorio H, Dias D, Pessegueiro H, Correia M, Coelho T (2015) CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings. J Neurol Neurosurg Psychiatry 86(2):159\u2013167. https:\/\/doi.org\/10.1136\/jnnp-2014-308107","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"4176_CR35","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1007\/s00415-016-8299-5","volume":"263","author":"A Franco","year":"2016","unstructured":"Franco A, Bentes C, de Carvalho M, Pereira P, Pimentel J, Conceicao I (2016) Epileptic seizures as a presentation of central nervous system involvement in TTR Val30Met-FAP. J Neurol 263(11):2336\u20132338. https:\/\/doi.org\/10.1007\/s00415-016-8299-5","journal-title":"J Neurol"},{"issue":"6","key":"4176_CR36","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.02.015","volume":"24","author":"F Salvi","year":"2015","unstructured":"Salvi F, Pastorelli F, Plasmati R, Morelli C, Rapezzi C, Bianchi A, Mascalchi M (2015) Brain microbleeds 12 years after orthotopic liver transplantation in Val30Met amyloidosis. J Stroke Cerebrovasc Dis 24(6):e149\u2013e151. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2015.02.015","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"4","key":"4176_CR37","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/13506129.2016.1256282","volume":"23","author":"P Goncalves","year":"2016","unstructured":"Goncalves P, Martins H, Costelha S, Maia LF, Saraiva MJ (2016) Efficiency of silencing RNA for removal of transthyretin V30M in a TTR leptomeningeal animal model. Amyloid 23(4):249\u2013253. https:\/\/doi.org\/10.1080\/13506129.2016.1256282","journal-title":"Amyloid"},{"issue":"2","key":"4176_CR38","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00415-017-8668-8","volume":"265","author":"A Martins da Silva","year":"2018","unstructured":"Martins da Silva A, Cavaco S, Fernandes J, Samoes R, Alves C, Cardoso M, Kelly JW, Monteiro C, Coelho T (2018) Age-dependent cognitive dysfunction in untreated hereditary transthyretin amyloidosis. J Neurol 265(2):299\u2013307. https:\/\/doi.org\/10.1007\/s00415-017-8668-8","journal-title":"J Neurol"},{"issue":"11","key":"4176_CR39","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1007\/s10072-018-3509-9","volume":"39","author":"JS Lee","year":"2018","unstructured":"Lee JS, Lee KM, Kim HG (2018) A case of recurrent transient ischemic attacks: carotid stump syndrome or posterior cerebral artery syndrome? Neurol Sci 39(11):1993\u20131995. https:\/\/doi.org\/10.1007\/s10072-018-3509-9","journal-title":"Neurol Sci"},{"issue":"12","key":"4176_CR40","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1007\/s10072-018-3546-4","volume":"39","author":"R Altavilla","year":"2018","unstructured":"Altavilla R, Anticoli S, Venti MP, Acciarresi M, Alberti A, Caso V, D'Amore C, Pezzella FR, Venti M, Agnelli G, Paciaroni M (2018) Clinical skills or high-tech MR in TIA patients: what makes the difference? Neurol Sci 39(12):2091\u20132096. https:\/\/doi.org\/10.1007\/s10072-018-3546-4","journal-title":"Neurol Sci"},{"issue":"8","key":"4176_CR41","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1212\/WNL.0000000000003001","volume":"87","author":"Y Sekijima","year":"2016","unstructured":"Sekijima Y, Yazaki M, Oguchi K, Ezawa N, Yoshinaga T, Yamada M, Yahikozawa H, Watanabe M, Kametani F, Ikeda S (2016) Cerebral amyloid angiopathy in posttransplant patients with hereditary ATTR amyloidosis. Neurology 87(8):773\u2013781. https:\/\/doi.org\/10.1212\/WNL.0000000000003001","journal-title":"Neurology"},{"issue":"9","key":"4176_CR42","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1161\/strokeaha.112.657759","volume":"43","author":"A Charidimou","year":"2012","unstructured":"Charidimou A, Peeters A, Fox Z, Gregoire SM, Vandermeeren Y, Laloux P, Jager HR, Baron JC, Werring DJ (2012) Spectrum of transient focal neurological episodes in cerebral amyloid angiopathy: multicentre magnetic resonance imaging cohort study and meta-analysis. Stroke 43(9):2324\u20132330. https:\/\/doi.org\/10.1161\/strokeaha.112.657759","journal-title":"Stroke"},{"issue":"2","key":"4176_CR43","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1136\/practneurol-2014-000952","volume":"15","author":"R Coates","year":"2015","unstructured":"Coates R, Bell SM, Coley S, Blackburn DJ (2015) Cerebral amyloid angiopathy: amyloid spells and cortical superficial siderosis. Pract Neurol 15(2):124\u2013126. https:\/\/doi.org\/10.1136\/practneurol-2014-000952","journal-title":"Pract Neurol"},{"issue":"1","key":"4176_CR44","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/wco.0000000000000510","volume":"31","author":"MJH Wermer","year":"2018","unstructured":"Wermer MJH, Greenberg SM (2018) The growing clinical spectrum of cerebral amyloid angiopathy. Curr Opin Neurol 31(1):28\u201335. https:\/\/doi.org\/10.1097\/wco.0000000000000510","journal-title":"Curr Opin Neurol"},{"issue":"5\u20136","key":"4176_CR45","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1159\/000381223","volume":"39","author":"J Ni","year":"2015","unstructured":"Ni J, Auriel E, Jindal J, Ayres A, Schwab KM, Martinez-Ramirez S, Gurol EM, Greenberg SM, Viswanathan A (2015) The characteristics of superficial siderosis and convexity subarachnoid hemorrhage and clinical relevance in suspected cerebral amyloid angiopathy. Cerebrovasc Dis (Basel, Switzerland) 39(5\u20136):278\u2013286. https:\/\/doi.org\/10.1159\/000381223","journal-title":"Cerebrovasc Dis (Basel, Switzerland)"},{"issue":"1","key":"4176_CR46","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1136\/practneurol-2013-000782","volume":"14","author":"V Nadarajan","year":"2014","unstructured":"Nadarajan V, Perry RJ, Johnson J, Werring DJ (2014) Transient ischaemic attacks: mimics and chameleons. Pract Neurol 14(1):23\u201331. https:\/\/doi.org\/10.1136\/practneurol-2013-000782","journal-title":"Pract Neurol"},{"key":"4176_CR47","doi-asserted-by":"publisher","unstructured":"Stanton JED, Chandratheva A, Wilson D, Hostettler IC, Islam S, Werring DJ (2019) Clinical features distinguish cerebral amyloid angiopathy-associated convexity subarachnoid haemorrhage from suspected TIA. J Neurol:1\u20135. https:\/\/doi.org\/10.1007\/s00415-019-09558-9","DOI":"10.1007\/s00415-019-09558-9"},{"issue":"1","key":"4176_CR48","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s00415-017-8693-7","volume":"265","author":"L Calviere","year":"2018","unstructured":"Calviere L, Raposo N, Cuvinciuc V, Cognard C, Bonneville F, Viguier A (2018) Patterns of convexal subarachnoid haemorrhage: clinical, radiological and outcome differences between cerebral amyloid angiopathy and other causes. J Neurol 265(1):204\u2013210. https:\/\/doi.org\/10.1007\/s00415-017-8693-7","journal-title":"J Neurol"},{"key":"4176_CR49","doi-asserted-by":"publisher","first-page":"116452","DOI":"10.1016\/j.jns.2019.116452","volume":"406","author":"M Vales-Montero","year":"2019","unstructured":"Vales-Montero M, Garcia-Pastor A, Iglesias-Mohedano AM, Esteban-de Antonio E, Salgado-Camara P, Garcia-Dominguez JM, Vazquez-Alen P, Diaz-Otero F, Fernandez-Bullido Y, Gil-Nunez A (2019) Cerebral amyloid angiopathy-related transient focal neurological episodes: a transient ischemic attack mimic with an increased risk of intracranial hemorrhage. J Neurol Sci 406:116452. https:\/\/doi.org\/10.1016\/j.jns.2019.116452","journal-title":"J Neurol Sci"},{"issue":"5","key":"4176_CR50","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1212\/wnl.38.5.674","volume":"38","author":"DE Levy","year":"1988","unstructured":"Levy DE (1988) How transient are transient ischemic attacks? Neurology 38(5):674\u2013677. https:\/\/doi.org\/10.1212\/wnl.38.5.674","journal-title":"Neurology"},{"issue":"17","key":"4176_CR51","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1212\/WNL.0b013e3181dad605","volume":"74","author":"J Linn","year":"2010","unstructured":"Linn J, Halpin A, Demaerel P, Ruhland J, Giese AD, Dichgans M, van Buchem MA, Bruckmann H, Greenberg SM (2010) Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology 74(17):1346\u20131350. https:\/\/doi.org\/10.1212\/WNL.0b013e3181dad605","journal-title":"Neurology"},{"issue":"7","key":"4176_CR52","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s10072-019-03868-6","volume":"40","author":"A Introna","year":"2019","unstructured":"Introna A, Mezzapesa DM, Petruzzellis M, Savarese M, Chiumarulo L, Zimatore DS, Dicuonzo F, Simone IL (2019) Convexal subarachnoid hemorrhage and acute ischemic stroke: a border zone matter? Neurol Sci 40(7):1419\u20131424. https:\/\/doi.org\/10.1007\/s10072-019-03868-6","journal-title":"Neurol Sci"},{"issue":"2","key":"4176_CR53","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1006\/bbrc.1995.1820","volume":"211","author":"Y Ando","year":"1995","unstructured":"Ando Y, Tanaka Y, Nakazato M, Ericzon BG, Yamashita T, Tashima K, Sakashita N, Suga M, Uchino M, Ando M (1995) Change in variant transthyretin levels in patients with familial amyloidotic polyneuropathy type I following liver transplantation. Biochem Biophys Res Commun 211(2):354\u2013358","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"4176_CR54","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1212\/01.WNL.0000065901.18353.AB","volume":"60","author":"G Blevins","year":"2003","unstructured":"Blevins G, Macaulay R, Harder S, Fladeland D, Yamashita T, Yazaki M, Hamidi Asl K, Benson MD, Donat JR (2003) Oculoleptomeningeal amyloidosis in a large kindred with a new transthyretin variant Tyr69His. Neurology 60(10):1625\u20131630","journal-title":"Neurology"},{"issue":"3","key":"4176_CR55","first-page":"497","volume":"31","author":"T Cavallaro","year":"1990","unstructured":"Cavallaro T, Martone RL, Dwork AJ, Schon EA, Herbert J (1990) The retinal pigment epithelium is the unique site of transthyretin synthesis in the rat eye. Invest Ophthalmol Vis Sci 31(3):497\u2013501","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"4176_CR56","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/0305-0491(93)90235-W","volume":"105","author":"G Schreiber","year":"1993","unstructured":"Schreiber G, Pettersson TM, Southwell BR, Aldred AR, Harms PJ, Richardson SJ, Wettenhall RE, Duan W, Nicol SC (1993) Transthyretin expression evolved more recently in liver than in brain. Comp Biochem Physiol B 105(2):317\u2013325","journal-title":"Comp Biochem Physiol B"},{"issue":"6","key":"4176_CR57","doi-asserted-by":"publisher","first-page":"430","DOI":"10.5692\/clinicalneurol.cn-000869","volume":"56","author":"Y Maetani","year":"2016","unstructured":"Maetani Y, Agari D, Nomura E, Ueda M, Ando Y, Yamawaki T (2016) Familial amyloid polyneuropathy involving a homozygous Val30Met mutation in the amyloidogenic transthyretin gene presenting with superficial siderosis: a case report. Rinsho Shinkeigaku 56(6):430\u2013434. https:\/\/doi.org\/10.5692\/clinicalneurol.cn-000869","journal-title":"Rinsho Shinkeigaku"},{"issue":"4","key":"4176_CR58","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3109\/13506120209114101","volume":"9","author":"K Haraoka","year":"2002","unstructured":"Haraoka K, Ando Y, Ando E, Sun X, Nakamura M, Terazaki H, Misumi S, Tanoue Y, Tajiri T, Shoji S, Ishizaki T, Okabe H, Tanihara H (2002) Presence of variant transthyretin in aqueous humor of a patient with familial amyloidotic polyneuropathy after liver transplantation. Amyloid 9(4):247\u2013251","journal-title":"Amyloid"},{"issue":"2","key":"4176_CR59","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3109\/13506129.2015.1015678","volume":"22","author":"JM Beirao","year":"2015","unstructured":"Beirao JM, Malheiro J, Lemos C, Beirao I, Costa P, Torres P (2015) Ophthalmological manifestations in hereditary transthyretin (ATTR V30M) carriers: a review of 513 cases. Amyloid 22(2):117\u2013122. https:\/\/doi.org\/10.3109\/13506129.2015.1015678","journal-title":"Amyloid"},{"issue":"6","key":"4176_CR60","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1046\/j.1440-1827.2001.01228.x","volume":"51","author":"N Sakashita","year":"2001","unstructured":"Sakashita N, Ando Y, Jinnouchi K, Yoshimatsu M, Terazaki H, Obayashi K, Takeya M (2001) Familial amyloidotic polyneuropathy (ATTR Val30Met) with widespread cerebral amyloid angiopathy and lethal cerebral hemorrhage. Pathol Int 51(6):476\u2013480","journal-title":"Pathol Int"},{"issue":"5","key":"4176_CR61","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/BF00310133","volume":"81","author":"M Ushiyama","year":"1991","unstructured":"Ushiyama M, Ikeda S, Yanagisawa N (1991) Transthyretin-type cerebral amyloid angiopathy in type I familial amyloid polyneuropathy. Acta Neuropathol 81(5):524\u2013528","journal-title":"Acta Neuropathol"},{"issue":"4","key":"4176_CR62","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1212\/WNL.47.4.988","volume":"47","author":"MK Herrick","year":"1996","unstructured":"Herrick MK, DeBruyne K, Horoupian DS, Skare J, Vanefsky MA, Ong T (1996) Massive leptomeningeal amyloidosis associated with a Val30Met transthyretin gene. Neurology 47(4):988\u2013992","journal-title":"Neurology"},{"issue":"7","key":"4176_CR63","first-page":"831","volume":"65","author":"SI Ikeda","year":"2013","unstructured":"Ikeda SI (2013) Cerebral amyloid angiopathy with familial transthyretin-derived oculoleptomeningeal amyloidosis. Brain Nerve 65(7):831\u2013842","journal-title":"Brain Nerve"},{"issue":"10","key":"4176_CR64","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1212\/WNL.43.10.2073","volume":"43","author":"SM Greenberg","year":"1993","unstructured":"Greenberg SM, Vonsattel JP, Stakes JW, Gruber M, Finklestein SP (1993) The clinical spectrum of cerebral amyloid angiopathy: presentations without lobar hemorrhage. Neurology 43(10):2073\u20132079","journal-title":"Neurology"},{"issue":"5","key":"4176_CR65","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1159\/000088665","volume":"20","author":"JA Roch","year":"2005","unstructured":"Roch JA, Nighoghossian N, Hermier M, Cakmak S, Picot M, Honnorat J, Derex L, Trouillas P (2005) Transient neurologic symptoms related to cerebral amyloid angiopathy: usefulness of T2*-weighted imaging. Cerebrovasc Dis 20(5):412\u2013414. https:\/\/doi.org\/10.1159\/000088665","journal-title":"Cerebrovasc Dis"},{"issue":"3","key":"4176_CR66","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1177\/1747493017741569","volume":"13","author":"A Corovic","year":"2018","unstructured":"Corovic A, Kelly S, Markus HS (2018) Cerebral amyloid angiopathy associated with inflammation: a systematic review of clinical and imaging features and outcome. Int J Stroke 13(3):257\u2013267. https:\/\/doi.org\/10.1177\/1747493017741569","journal-title":"Int J Stroke"},{"issue":"2","key":"4176_CR67","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.abb.2013.03.005","volume":"535","author":"F Zhang","year":"2013","unstructured":"Zhang F, Hu C, Dong Y, Lin MS, Liu J, Jiang X, Ge Y, Guo Y (2013) The impact of V30A mutation on transthyretin protein structural stability and cytotoxicity against neuroblastoma cells. Arch Biochem Biophys 535(2):120\u2013127. https:\/\/doi.org\/10.1016\/j.abb.2013.03.005","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"4176_CR68","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5853\/jos.2015.17.1.17","volume":"17","author":"M Yamada","year":"2015","unstructured":"Yamada M (2015) Cerebral amyloid angiopathy: emerging concepts. J Stroke 17(1):17\u201330. https:\/\/doi.org\/10.5853\/jos.2015.17.1.17","journal-title":"J Stroke"},{"issue":"2","key":"4176_CR69","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1097\/TP.0000000000001975","volume":"102","author":"N Wange","year":"2018","unstructured":"Wange N, Anan I, Ericzon BG, Pennlert J, Pilebro B, Suhr OB, Wixner J (2018) Atrial fibrillation and central nervous complications in liver transplanted hereditary transthyretin amyloidosis patients. Transplantation 102(2):e59\u2013e66. https:\/\/doi.org\/10.1097\/TP.0000000000001975","journal-title":"Transplantation"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-019-04176-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-019-04176-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-019-04176-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T01:25:45Z","timestamp":1609464345000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-019-04176-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,2]]},"references-count":69,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["4176"],"URL":"https:\/\/doi.org\/10.1007\/s10072-019-04176-9","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,2]]},"assertion":[{"value":"5 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study received the approval of the Cyprus National Ethics Committee \u0395\u0395\u0392\u039a\/\u0395\u03a0\/2015\/36 and written informed consent granted by the participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}